Mereo BioPharma (MREO) Return on Assets (2024 - 2026)

Mereo BioPharma (MREO) has reported Return on Assets for 3 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Assets declined to 0.01% in Q1 2026 per MREO's latest filing, from 0.01% in the prior quarter.
• Over the last five years, Return on Assets for MREO reached as high as 0.0% in Q1 2024 and fell as low as 0.01% in Q1 2026.
• A 3-year average of 0.01% and a median of 0.01% in 2025 frame the typical range for Return on Assets.
• The largest YoY upside for Return on Assets was 0 bps in 2025 against a maximum downside of 0 bps in 2025.
• Year by year, Return on Assets stood at 0.01% in 2024, then sank by 60 bps to 0.01% in 2025, then declined by 1 bps to 0.01% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.01%, 0.01%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.